发明名称 CONTROL OF CARDIAC ARRHYTHMIAS BY MODIFICATION OF NEURONAL CONDUCTION WITHIN FAT PADS OF THE HEART
摘要 To control cardiac arrhythmias, various conduction-modifying agents include biopolymers, fibroblasts, neurotoxins, and growth factors are introduced either epicardially or endocardially to the fat pads in proximity to the ganglia therein. Any desired technique may be used for injection , including injection from a catheter inserted percutaneously, or direct injection through the epicardial during open heart surgery. Preferably the patient's heart is beating throughout the Injection.
申请公布号 WO2005049111(A2) 申请公布日期 2005.06.02
申请号 WO2004US38128 申请日期 2004.11.15
申请人 SYMPHONY MEDICAL, INC.;MACIEJEWSKI, MARK;PETERS, NICHOLAS, S. 发明人 MACIEJEWSKI, MARK;PETERS, NICHOLAS, S.
分类号 A61M;A61N1/362 主分类号 A61M
代理机构 代理人
主权项
地址